Wayve's licensing model gives it access to automakers selling tens of millions of vehicles annually, bypassing Tesla's closed-system approach.
UK-based Wayve has emerged as a serious challenger to Tesla and Waymo in autonomous driving, licensing its "AI Driver" to Stellantis and potentially Nissan — giving it access to automakers that sell more than 10 million vehicles a year combined.
"Not everyone wants to buy a Tesla. Our opportunity is to bring this technology to every other automaker," Alex Kendall, co-founder of Wayve, told the Wall Street Journal.
Stellantis, which owns Jeep, Dodge, Chrysler, and Fiat among over a dozen global brands, has begun working with Wayve. Nissan may also adopt the system. By contrast, Tesla's Full Self-Driving (Supervised) system is exclusive to Tesla vehicles, limiting its addressable market to the roughly 1.8 million vehicles the company delivered last year. Waymo, owned by Alphabet, operates its own robotaxi fleet but has not licensed its technology to other automakers at scale.
The competitive threat arrives as Tesla faces mounting regulatory pressure. The company recently settled a lawsuit over a fatal 2023 crash involving FSD, and the National Highway Traffic Safety Administration has escalated its probe to an engineering analysis — the final step before a possible recall of the software Tesla has pitched as central to its valuation.
The Licensing Advantage
Wayve's strategy mirrors what Google's Android did to Apple's iOS in smartphones: offer the technology to every manufacturer rather than keeping it exclusive. On paper, Wayve and Waymo could be adopted by multiple car companies worldwide, reaching tens of millions of new vehicle sales annually. Tesla, which delivered about 1.8 million vehicles in 2025, cannot match that scale through its own production alone.
The approach also spreads development costs across multiple partners. Wayve's AI Driver uses an end-to-end learning system trained on real-world driving data from multiple automakers' fleets, potentially accelerating its improvement cycle compared with Tesla's single-source data pipeline. The company has not disclosed its training compute or data volume, but its partnerships with automakers producing millions of vehicles annually suggest a data advantage over time.
The Regulatory Bottleneck
All three companies face the same fundamental hurdle: city-by-city government approval. Tesla and Waymo operate trials in select cities, but no jurisdiction has approved any self-driving vehicle for public sale. Waymo has logged more than 100,000 paid robotaxi trips in a single week in San Francisco and Phoenix, yet remains confined to approved geographies with limited expansion timelines.
Safety concerns persist despite evidence that autonomous systems may be safer than human drivers. The 2023 death of Johna Story in Arizona — the first known pedestrian fatality involving Tesla's FSD — triggered a federal investigation that NHTSA escalated to an engineering analysis in March 2026. The agency wrote that Tesla's system "fails to detect and/or warn the driver appropriately under degraded visibility conditions such as glare and airborne obscurants." Tesla has since said it changed cameras on older vehicles to address the issue.
A separate NHTSA inquiry opened in late 2025 is examining reports of FSD running red lights and drifting into the wrong lane. In Texas this month, a Tesla struck a home and killed a 76-year-old woman, with the driver blaming Autopilot. Both NHTSA and the National Transportation Safety Board have opened investigations into that crash.
For investors, the calculus is shifting. Tesla shares trade at a premium multiple partly justified by its autonomous driving ambitions. If Wayve's licensing model gains traction with major automakers, Tesla's first-mover advantage erodes. Stellantis and Nissan represent a combined annual production of more than 10 million vehicles — a scale Tesla cannot match through exclusivity alone. The question is whether regulators will clear any system for broad deployment, and how quickly.
This article is for informational purposes only and does not constitute investment advice.